-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MDZdyK3sxSOLZF/d1NmtTxktmmMguysf1BstUMeX6j9gZaRJgVxGbjoIeulS728M wiwegQTxIDmiOfvj6IeoQg== 0001144204-10-012501.txt : 20100310 0001144204-10-012501.hdr.sgml : 20100310 20100310160421 ACCESSION NUMBER: 0001144204-10-012501 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100308 FILED AS OF DATE: 20100310 DATE AS OF CHANGE: 20100310 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PERRI ROSE C CENTRAL INDEX KEY: 0001125858 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-25169 FILM NUMBER: 10670600 MAIL ADDRESS: STREET 1: 33 HARBOUR SQUARE STE 202 STREET 2: TORONTO ONTARIO CITY: CANADA M5H2G2 STATE: A1 ZIP: 00000 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENEREX BIOTECHNOLOGY CORP CENTRAL INDEX KEY: 0001059784 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 820490211 STATE OF INCORPORATION: DE FISCAL YEAR END: 0731 BUSINESS ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CANADA STATE: A1 ZIP: M5J 2G2 BUSINESS PHONE: 4163642551 MAIL ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CA STATE: A1 ZIP: M5J 2G2 4 1 v176792_ex.xml X0303 4 2010-03-08 0 0001059784 GENEREX BIOTECHNOLOGY CORP GNBT 0001125858 PERRI ROSE C 33 HARBOUR SQUARE, SUITE 202 TORONTO A6 M5J 2G2 ONTARIO, CANADA 1 1 0 0 COO, CFO, Treas. & Secy. Common Stock Purchase Option (right to buy) .61 2009-10-20 4 D 0 250000 0 D 2009-12-12 Common Stock 250000 0 D Common Stock Purchase Option (right to buy) .61 2009-10-20 4 A 0 250000 0 A 2014-10-26 Common Stock 250000 250000 D Common Stock Purchase Option (right to buy) .001 2009-10-20 4 D 0 576572 0 D 2010-04-05 Common Stock 576752 0 D Common Stock Purchase Option (right to buy) .001 2009-10-20 4 A 0 576572 0 A 2014-10-26 Common Stock 576752 576752 D Common Stock Purchase Option (right to buy) .64 2010-03-08 4 A 0 400000 0 A 2020-03-07 Common Stock 400000 400000 D Deemed cancellation of option in connection with deemed grant of replacement option. The reported transaction involved the extension of the term of existing options through October 26, 2014 as previously reported in the issuer's Current Report on Form 8-K filed on October 23, 2009. The option becomes exercisable in three installments, with the first installment (133,333 shares) exercisable as of the date of grant, the second installment (133,333 shares) exercisable as of August 1, 2010 and the third installment (133,334 shares) exercisable as of August 1, 2011. /s/ Rose C. Perri 2010-03-10 -----END PRIVACY-ENHANCED MESSAGE-----